DeltaShares S&P 500 Managed Risk ETF
DMRL
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- DE United States of America
- IPO Date
- Jul 31, 2017
- CIK
- 0001673996
- Similar Companies
- Business
- DeltaShares S&P 500 Managed Risk ETF (DMRL) seeks to track the investment results, before fees and expenses, of the S&P 500 Managed Risk 2.0 Index; under normal market conditions, the fund invests a substantial portion, but at least 80%, of its assets, exclusive of collateral held from securities lending, in securities comprising the index or depositary receipts based thereon; the index methodology incorporates managed futures overlays designed to mitigate downside risk relative to the traditional S&P 500 Index. Launched in 2017 as part of the DeltaShares suite of strategic beta ETFs by Transamerica ETF Trust, with Transamerica Asset Management, Inc. serving as investment adviser and Milliman Financial Risk Management LLC as sub-adviser, the ETF targeted institutional and retail investors seeking equity exposure with enhanced risk management features. Headquartered through its adviser in the United States, the fund operated primarily in U.S. equity markets with a focus on large-cap stocks. In a major strategic shift, Transamerica Asset Management announced on March 8, 2022, the decision to liquidate and close DMRL along with four other DeltaShares ETFs (DMRM, DMRS, DMRI, and DMRE) due to insufficient assets under management and a refocus on actively managed strategies; trading ceased on NYSE Arca after market close on April 7, 2022, with final liquidation distributions to remaining shareholders on or about April 12, 2022. This closure marked the end of the DeltaShares brand, as Transamerica determined the strategic beta products failed to gain sufficient traction despite their innovative risk-managed indexing approach. No subsequent relaunches, partnerships, or acquisitions involving DMRL have been reported, and the ticker is now delisted.